UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:
Former name or former address, if changed since last report: N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 5, 2022, Gentherm Incorporated (the “Company”) announced that Nicholas Breisacher, age 39, was appointed as the Chief Accounting Officer of the Company, effective immediately.
Mr. Breisacher served as the Company’s Director of Financial Reporting since April 2019. Previously, he held several positions over approximately 13 years at Ernst & Young, LLP. He served as a Senior Manager, Assurance Services from October 2014 to April 2019. During such time, he was responsible for numerous public and private companies across various industries, primarily global automotive component suppliers and medical device suppliers. At Ernst & Young, LLP, he had extensive experience with U.S. GAAP and SEC reporting, internal control over financial reporting, and coordinating global audits. Mr. Breisacher holds a Master of Science in Accounting and a Bachelor of Arts in Accounting from the Eli Broad College of Business at Michigan State University.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GENTHERM INCORPORATED | ||||||
| By: | /s/ Wayne Kauffman | |||||
| Wayne Kauffman | ||||||
| Senior Vice President, General Counsel and Secretary | ||||||
| Date: August 8, 2022 | ||||||
3